Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
09/2013
09/03/2013CA2558211C Bicyclic and bridged nitrogen heterocycles
09/03/2013CA2548662C Maleate salts of a quinazoline derivative useful as an antiangiogenic agent
09/03/2013CA2522562C 2-phenyl-benzimidazol and 2-phenyl-imidazo-`4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer
08/2013
08/29/2013US20130225831 Radio-methyl Vorozole and Methods for Making and Using the Same
08/29/2013US20130225819 Use of azides in synthesis
08/29/2013US20130225805 Preparation of crystalline bazedoxifene and its salts
08/29/2013US20130225644 Modified lysine-mimetic compounds
08/29/2013US20130225620 Serine/threonine kinase inhibitors
08/29/2013US20130225617 Indoles and their therapeutic use
08/29/2013US20130225615 2-cycloquinazoline derivatives and methods of use thereof
08/29/2013US20130225614 4-azolylaminoquinazoline derivatives and methods of use thereof
08/29/2013US20130225606 N-hetarylmethyl pyrazolylcarboxamides
08/29/2013US20130225599 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
08/29/2013US20130225584 2-(benzyloxy) benzamides as lrrk2 kinase inhibitors
08/29/2013US20130225583 Substituted amino-triazolyl pde10 inhibitors
08/29/2013US20130225580 Aza-aryl 1h-pyrazol-1-yl benzene sulfonamides
08/29/2013US20130225578 7-cyclylquinazoline derivatives and methods of use thereof
08/29/2013US20130224107 Heterocyclic derivates, preparation processes and medical uses thereof
08/28/2013EP2631233A1 Antagonist for mutated androgen receptor
08/28/2013EP2631229A1 P2x4 receptor antagonist
08/28/2013EP2630682A1 Organic electroluminescent device
08/28/2013EP2630140A1 Organic electroluminescent device
08/28/2013EP2630139A1 Amino-pyrrolidine-azetidine diamides as monoacylglycerol lipase inhibitors
08/28/2013EP2630138A2 1-(heterocyclic carbonyl)-2-substituted pyrrolidines and their use as fungicides
08/28/2013EP2630134A1 Pyridine- 2- derivatives as smoothened receptor modulators
08/28/2013EP2630130A1 Method for preparing substituted n-(3-amino-quinoxalin-2-yl)-sulfonamides and their intermediates n-(3-chloro-quinoxalin-2-yl)sulfonamides
08/28/2013EP2630129A1 Quinoxaline derivates
08/28/2013EP2630128A1 Viral polymerase inhibitors
08/28/2013EP2629616A2 Substituted amino-triazolyl pde10 inhibitors
08/28/2013CN103270032A Aromatic heterocycle derivative and organic electroluminescent element using same
08/28/2013CN103270031A Substituted sodium-1H-pyrazole-5-olate
08/28/2013CN103270030A Hydrobromide salts of a pyrazolylaminoquinazoline
08/28/2013CN103270027A Method for preparing substituted n-3-amino-quinoxalin-<wbr/>2-yl)-sulfonamides and their intermediates n-<wbr/>(3-chloro-quinoxalin-<wbr/>2-yl)sulfonamides
08/28/2013CN103265534A Method for preparing avanafil
08/28/2013CN103265533A Crystal modifications -3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-1-yl) -quinazolin-4-yl] -pyrrole-2, 5-d ione
08/28/2013CN103265532A Preparation method of C-type candesartan cilexetil crystal
08/28/2013CN103265477A Aminoheteroaryl compounds as protein kinase inhibitors
08/28/2013CN102190625B Stilbene tumor targeted medicine Combretastatin A4 analogs
08/28/2013CN102026974B Tetrahydrocyclopenta[b]indole androgen receptor modulators
08/28/2013CN101981006B Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
08/28/2013CN101535276B Fused bicyclic derivatives of 2,4-diaminopyrimidine as ALK and c-MET inhibitors
08/27/2013US8519129 Pyrimidine derivatives as kinase inhibitors
08/27/2013US8519124 Chemokine receptor antagonists and use thereof
08/27/2013US8518999 Modulators of TNF-αsignaling
08/27/2013US8518983 P38 inhibitors and methods of use thereof
08/27/2013US8518975 Gamma secretase modulators
08/27/2013US8518950 2-amido pyrazines for inflammation and immune related uses
08/27/2013US8518944 Compounds as casein kinase inhibitors
08/27/2013US8518936 Method for preparing acid addition salts of polyacidic basic compounds
08/27/2013CA2657776C Triazolyl phenyl benzenesulfonamides
08/27/2013CA2649741C Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
08/27/2013CA2603939C Bicyclic [3.1.0] heteroaryl amides as type i glycine transport inhibitors
08/27/2013CA2531868C Process for the preparation of thalidomide
08/27/2013CA2518774C Heterocyclic n-aryl carboxamides as cytokine inhibitors
08/22/2013WO2013123511A1 Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics
08/22/2013WO2013123444A1 Sulfonyl compounds that interact with glucokinase regulatory protein
08/22/2013WO2013123401A1 Diaminopyrimidines useful as inhibitors of the human respiratory syncytial virus (rsv)
08/22/2013WO2013123277A1 Tricyclic indole derivatives useful endothelial lipase inhibitors
08/22/2013WO2013120921A1 Novel pyrrolidine derivatives
08/22/2013WO2013120835A1 Isoindoline derivatives, pharmaceutical compositions containing them, and their use in therapy
08/22/2013WO2013101911A3 Benzimidazole derivatives as selective blockers of persistent sodium current
08/22/2013WO2013094999A3 Organic compound, and organic electroluminescent device using same
08/22/2013WO2013081420A3 Phenoxypropanol derivative and pharmaceutical composition containing same
08/22/2013US20130217887 Compounds With Matrix-Metalloproteinase Inhibitory Activity and Imaging Agents Thereof
08/22/2013US20130217727 1-(heterocyclic carbonyl)-2-substituted pyrrolidines
08/22/2013US20130217715 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents
08/22/2013US20130217709 Cyclic Amine Azaheterocyclic Carboxamides
08/22/2013US20130217702 Indole derivatives
08/22/2013US20130217700 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
08/22/2013US20130217688 Heteroaryl compounds and uses thereof
08/22/2013US20130217685 Compounds for modulating rna binding proteins and uses therefor
08/22/2013US20130217679 Compositions and Methods for Treatment of Neurodegenerative Disease
08/22/2013US20130217676 5ht2c receptor modulators
08/22/2013US20130217669 Azetidinyl diamides as monoacylglycerol lipase inhibitors
08/22/2013US20130217668 Benzimidazole and azabenzimidazole compounds that inhibit anaplastic lymphoma kinase
08/22/2013US20130217665 Novel pyrrolidine derivatives
08/22/2013US20130216477 Metal complexes of poly(carboxyl)amine-containing ligands having an affinity for carbonic anhydrase ix
08/22/2013US20130216475 Methods and compositions for protein labelling
08/22/2013US20130214258 Carbazole compound, material for organic electroluminescence device and organic electroluminescence device
08/21/2013EP2628727A2 Biaryl PDE4 inhibitors for treating pulmonary and cardiovascular disorders
08/21/2013EP2628726A1 Hydroxamate-based inhibitors of deacetylases b
08/21/2013EP2628481A1 Trisubstituted heterocycles as replication inhibitors of hepatitis C virus HCV
08/21/2013EP2627651A1 Anti-viral compounds
08/21/2013EP2627650A2 N-phenyl imidazole carboxamide inhibitors of 3-phosphoinositide-dependent protein kinase-1
08/21/2013EP2627637A1 N-pyridin-3-yl or n-pyrazin-2-yl carboxamides
08/21/2013EP2627634A1 A new dimedon derivative and a method for the purification of pna and peptide oligomers
08/21/2013EP2627631A1 Pyrrolidinones as metap2 inhibitors
08/21/2013CN103262283A Organic electroluminescent element
08/21/2013CN103261189A Amino-pyrrolidine-zetidine diamides as monoacylglycerol lipase inhibitors
08/21/2013CN103261188A Insecticidal compounds
08/21/2013CN103261185A Continuous arycyclic compound
08/21/2013CN103261165A 胰高血糖素受体调节剂 Glucagon receptor modulators
08/21/2013CN103261156A New compounds for the treatment of neurodegenerative diseases
08/21/2013CN103260622A Novel fused pyridine compounds as casein kinase inhibitors
08/21/2013CN103254892A Solid broadband blue-light transmitting organic luminescent material and preparation method thereof
08/21/2013CN103254180A Preparation method of Avanafil
08/21/2013CN103254179A Preparation method of Avanafil
08/21/2013CN103254178A Triazine compound, pigment dispersing aid, pigment dispersion and resist composition
08/21/2013CN103254177A Modulators of atp-binding cassette transporters
08/21/2013CN103254176A Salt of trachycladindole A derivative
1 ... 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 ... 626